355 related articles for article (PubMed ID: 16457333)
21. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?
Liebling M; Rubio E; Ie S
Expert Rev Respir Med; 2015 Apr; 9(2):171-81. PubMed ID: 25771943
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
24. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
25. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
Maldonado YA; Araneta RG; Hersh AL
Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
27. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
Komano Y; Harigai M; Koike R; Sugiyama H; Ogawa J; Saito K; Sekiguchi N; Inoo M; Onishi I; Ohashi H; Amamoto F; Miyata M; Ohtsubo H; Hiramatsu K; Iwamoto M; Minota S; Matsuoka N; Kageyama G; Imaizumi K; Tokuda H; Okochi Y; Kudo K; Tanaka Y; Takeuchi T; Miyasaka N
Arthritis Rheum; 2009 Mar; 61(3):305-12. PubMed ID: 19248121
[TBL] [Abstract][Full Text] [Related]
29. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
[TBL] [Abstract][Full Text] [Related]
30. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
31. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
[TBL] [Abstract][Full Text] [Related]
32. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial.
Newberry L; O'Hare B; Kennedy N; Selman A; Omar S; Dawson P; Stevenson K; Nishihara Y; Lissauer S; Molyneux E
Paediatr Int Child Health; 2017 May; 37(2):121-128. PubMed ID: 28145162
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids.
Jinno S; Akashi K; Onishi A; Nose Y; Yamashita M; Saegusa J
Rheumatol Int; 2022 Aug; 42(8):1403-1409. PubMed ID: 34263352
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Evans RA; Clifford TM; Tang S; Au T; Fugit AM
Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.
Katsuyama T; Saito K; Kubo S; Nawata M; Tanaka Y
Arthritis Res Ther; 2014 Feb; 16(1):R43. PubMed ID: 24495443
[TBL] [Abstract][Full Text] [Related]
36. [Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series].
Blum T; Roth A; Mauch H; Erbes R; Lode H
Dtsch Med Wochenschr; 2006 Jul; 131(27):1515-20. PubMed ID: 16817100
[TBL] [Abstract][Full Text] [Related]
37. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole.
Olsen SL; Renlund DG; O'Connell JB; Taylor DO; Lassetter JE; Eastburn TE; Hammond EH; Bristow MR
Transplantation; 1993 Aug; 56(2):359-62. PubMed ID: 8356591
[TBL] [Abstract][Full Text] [Related]
38. Question 1: Co-trimoxazole dosing dilemma: what is the right dose?
Boast A; Osowicki J; Cole T; Curtis N; Gwee A
Arch Dis Child; 2015 Nov; 100(11):1089-93. PubMed ID: 26408788
[No Abstract] [Full Text] [Related]
39. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
[TBL] [Abstract][Full Text] [Related]
40. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
Lindemulder S; Albano E
Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
